Press Releases

 
Press Releases
  Date Title and Summary View
Dec 14, 2011
San Diego, California – Biocept, Inc., a privately?held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells in cancer patients, announced today the publication of a paper on research performed with collaborators from the University of Texas MD Anderson Cancer Center entitled “Novel ...
Nov 15, 2011
San Diego, CA ? Biocept, Inc. today reported that its scientists and academic collaborators will present three posters at the 34th annual San Antonio Breast Cancer Symposium (SABCS) taking place in San Antonio, TX December 6?10, 2011. The poster presentations describe data generated on Biocept’s proprietary OncoCEETM (Oncology Cell Enrichm...
Nov 10, 2011
San Diego, California: ? Biocept, Inc., a privately?held CLIA?certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in blood samples from cancer patients, announced today that the US Patent and Trademark Office has allowed its patent application covering its microchannel capture device deve...
Sep 23, 2011
San Diego, California: – Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced today the publication of a paper describing an analysis of CTC capture using its proprietary Cell Enrichment and Extraction (CEETM) platfor...
Aug 24, 2011
San Diego, California: ? Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in cancer patients, and Clarient, Inc. (a GE Healthcare Company) today announced a collaboration on the commercialization of a proprietary blood test for CTCs in breast cancer...
Jul 28, 2011
Capture, detection and enumeration Determination of HER2/neu status Biocept, Inc., an advanced diagnostic CLIA-certified service laboratory developing novel tests for the oncology community, today announced the availability of OncoCEE-BR™ for breast cancer, a test designed to detect circulating tumor cells (C...
Jul 15, 2011
Biocept, Inc. announced today that it has appointed William G. Kachioff as Senior Vice President, Finance and Chief Financial Officer. As CFO, Mr. Kachioff will be responsible for management of the company’s accounting, finance, treasury, investor relations, risk management and information systems functions. Kachioff has more than 20 years...
Jun 2, 2011
Biocept, Inc. today reported that its scientists and academic collaborators will present a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, Illinois June 3?7. The poster presentation is based on studies performed utilizing Biocept’s proprietary OncoCEE™ (Oncology Cell Enri...
May 10, 2011
San Diego, California: ? Biocept, Inc., a privately?held laboratory testing company focused on the detection, enumeration and analysis of circulating tumor cells (CTCs) in cancer patients, today announced the publication of a paper describing the identification of different CTC phenotypes using its proprietary Cell Enrichment and Extraction (CEE...
Apr 22, 2011
SAN DIEGO / — Biocept, Inc. announced today that Lyle Arnold, PhD and Michael Dunn, MBA have joined Biocept’s Management Team. Dr. Arnold will serve as Senior Vice President and Chief Scientific Officer (CSO) and Mr. Dunn will act as the Senior Vice President, Corporate Development. “I am very excited about the addition...
Page: FirstPrevious ...
16
NextLast
= add release to Briefcase